An 18-month-old in London, England, is one of the youngest children to receive gene therapy to treat hearing loss caused by a mutation in the OTOF gene. This gene produces a protein called Otoferlin that allows for communication between cells of the cochlea and the brain.
The recipient received an infusion of a functional copy of the OTOF in her ear. The procedure was completed in just 16 minutes. Reportedly, it only took a few weeks for the child to begin to hear and respond to sounds without the help of her cochlear implant.
References
Afzali K. (2024) Toddler born deaf can hear after gene therapy trial breakthrough her parents call “mind-blowing.”CBS News(accessed May 13, 2024).
Recent Posts
Some Fish Hear with Their Bones and Communicate in an Unusual Way
We love to scratch the ears of our pets, and when we think of animal ears, we think of fur-covered appendages that are small, large,…
Advancing Audiology: SPAN Wraps Up 2025 with Key Updates on CPT Codes
The State Policy Advocate Network (SPAN) held its final meeting of the year last week, closing out the fourth quarter with a focus on critical…
Audiology and Speech-Language Pathology Interstate Compact Update
The Audiology and Speech-Language Pathology Interstate Compact (ASLP-IC) Commission recently announced that the CompactConnect data system has officially launched! CompactConnect is the data system that…


